Latest autoimmune diseases Stories
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
LifeScienceIndustryResearch.com adds “OpportunityAnalyzer: Celiac Disease – Opportunity Analysis and Forecast to 2023” report to its store. Dallas, TX
TORONTO, Feb. 17, 2015 /CNW/ - Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a promising new approach to treat multiple sclerosis (MS).
PORTLAND, Ore., Feb.
-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) LAKE FOREST, Ill., Feb.
CCFA, AGA and Janssen Biotech Announce New Grant Program NEW YORK, Feb.
MISSISSAUGA, ON, Feb. 12, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc.
CRANBURY, N.J., Feb.
-- CHABLIS-SC1 study passes futility analysis and will continue to completion with an enhanced endpoint HAYWARD, Calif., Feb.
DALLAS, February 4, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Ulcerative Colitis - Pipeline Review, H1 2015" to its store.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).